Iron deficiency: Prevalence and relation to cardiovascular biomarkers in heart failure outpatients

International Journal of Cardiology

Volumn 195, Issue , 2015, Pages 143-148

  Schou, Morten ^a   Bosselmann, Helle ^b   Gaborit, Freja ^a   Iversen, Kasper ^a   Goetze, Jens P ^c   Soletomas, Georg ^b   Rasmussen, Jon ^a   Kistorp, Caroline ^a   Kober, Lars ^c   Gustafsson, Finn ^c   Tonder, Niels ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b HILLERØD HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Cardiac biomarkers; Heart failure; Heart failure clinic; Inflammation; Iron deficiency

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARDIOVASCULAR BIOMARKER; CHROMOGRANIN A; COPEPTIN; FERRITIN; HEMOGLOBIN A1C; MID REGIONAL PRO ATRIAL NATRIURETIC PEPTIDE; TRANSFERRIN; TROPONIN I; UNCLASSIFIED DRUG; BRAIN NATRIURETIC PEPTIDE; GLYCOPEPTIDE; IRON; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON METABOLISM; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MORTALITY; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SYSTOLIC HEART FAILURE; THROMBOCYTE COUNT; BLOOD; COMORBIDITY; DEFICIENCY; DENMARK; HEART FAILURE, SYSTOLIC; IRON METABOLISM DISORDERS; KAPLAN MEIER METHOD; METABOLISM; STATISTICS;

AGED; BIOMARKERS; C-REACTIVE PROTEIN; CHROMOGRANIN A; COMORBIDITY; DENMARK; FEMALE; FERRITINS; GLYCOPEPTIDES; HEART FAILURE, SYSTOLIC; HUMANS; IRON; IRON METABOLISM DISORDERS; KAPLAN-MEIER ESTIMATE; MALE; NATRIURETIC PEPTIDE, BRAIN; OUTPATIENTS; PEPTIDE FRAGMENTS; PREVALENCE; PROGNOSIS; STATISTICS AS TOPIC; TRANSFERRIN; TROPONIN I;

EID: 84937574014     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.05.096     Document Type: Article

References (19)

1. E.A. Jankowska, S. von Haehling, S.D. Anker, I.C. Macdougall, and P. Ponikowski Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives Eur. Heart J. 34 2013 816 829 (Review)
2. E.A. Jankowska, P. Rozentryt, A. Witkowska, J. Nowak, O. Hartmann, B. Ponikowska, L. Borodulin-Nadzieja, W. Banasiak, L. Polonski, G. Filippatos, J.J. McMurray, S.D. Anker, and P. Ponikowski Iron deficiency: an ominous sign in patients with systolic chronic heart failure Eur. Heart J. 31 2010 1872 1880
3. D.O. Okonko, A.K. Mandal, C.G. Missouris, and P.A. Poole-Wilson Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival J. Am. Coll. Cardiol. 58 2011 1241 1251
4. E.A. Jankowska, P. Rozentryt, A. Witkowska, J. Nowak, O. Hartmann, B. Ponikowska, L. Borodulin-Nadzieja, S. von Haehling, W. Doehner, W. Banasiak, L. Polonski, G. Filippatos, S.D. Anker, and P. Ponikowski Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure J. Card. Fail. 17 2011 899 906
5. S.D. Anker, J. Comin Colet, G. Filippatos, R. Willenheimer, K. Dickstein, H. Drexler, T.F. Lüscher, B. Bart, W. Banasiak, J. Niegowska, B.A. Kirwan, C. Mori, B. von Eisenhart Rothe, S.J. Pocock, P.A. Poole-Wilson, P. Ponikowski, and FAIR-HF Trial Investigators Ferric carboxymaltose in patients with heart failure and iron deficiency N. Engl. J. Med. 361 2009 2436 2448
6. L. Beck-da-Silva, D. Piardi, S. Soder, L.E. Rohde, A.C. Pereira-Barretto, D. de Albuquerque, E. Bocchi, F. Vilas-Boas, L.Z. Moura, M.W. Montera, S. Rassi, and N. Clausell IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia Int. J. Cardiol. 168 2013 3439 3442
7. I.T. Klip, J. Comin-Colet, A.A. Voors, P. Ponikowski, C. Enjuanes, W. Banasiak, D.J. Lok, P. Rosentryt, A. Torrens, L. Polonski, D.J. van Veldhuisen, P. van der Meer, and E.A. Jankowska Iron deficiency in chronic heart failure: an international pooled analysis Am. Heart J. 165 2013 575 582
8. H. Bosselmann, N. Tonder, G. Sölétormos, K. Rossing, K. Iversen, J.P. Goetze, F. Gustafsson, and M. Schou Influence of renal impairment on myocardial function in outpatients with systolic heart failure: an echocardiographic and cardiac biomarker study Int. J. Cardiol. 177 2014 942 948
9. U. Alehagen, U. Dahlström, J.F. Rehfeld, and J.P. Goetze Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure JAMA 305 2011 2088 2095
10. I. Hunter, J.F. Rehfeld, and J.P. Goetze Measurement of the total proANP product in mammals by processing independent analysis J. Immunol. Methods 370 2011 104 110
11. J.P. Goetze, L.M. Hilsted, J.F. Rehfeld, and U. Alehagen Plasma chromogranin A is a marker of death in elderly patients presenting with symptoms of heart failure Endocr. Connect. 3 1 Mar 11 2014 47 56
12. 2 Am. J. Kidney Dis. 56 2010 486 495
13. H.M. Christensen, J. Frystyk, J. Faber, M. Schou, A. Flyvbjerg, P. Hildebrandt, I. Raymond, T.W. Klausen, and C. Kistorp α-Defensins and outcome in patients with chronic heart failure Eur. J. Heart Fail. 14 2012 387 394
14. O. Tarim, A. Küçükerdoʇan, U. Günay, O. Eralp, and I. Ercan Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus Pediatr. Int. 41 1999 357 362
15. E.A. Jankowska, J. Malyszko, H. Ardehali, E. Koc-Zorawska, W. Banasiak, S. von Haehling, I.C. Macdougall, G. Weiss, J.J. McMurray, S.D. Anker, M. Gheorghiade, and P. Ponikowski Iron status in patients with chronic heart failure Eur. Heart J. 34 2013 827 834
16. E.A. Jankowska, M. Kasztura, M. Sokolski, M. Bronisz, S. Nawrocka, W. Oles̈kowska-Florek, R. Zymliński, J. Biegus, P. Siwołowski, W. Banasiak, S.D. Anker, G. Filippatos, J.G. Cleland, and P. Ponikowski Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure Eur. Heart J. 21 2014 2468 2476
17. J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Böhm, K. Dickstein, V. Falk, G. Filippatos, C. Fonseca, M.A. Gomez-Sanchez, T. Jaarsma, L. Køber, G.Y. Lip, A.P. Maggioni, A. Parkhomenko, B.M. Pieske, B.A. Popescu, P.K. Rønnevik, F.H. Rutten, J. Schwitter, P. Seferovic, J. Stepinska, P.T. Trindade, A.A. Voors, F. Zannad, A. Zeiher, Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, J.J. Bax, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, P. Kirchhof, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, M. Tendera, A. Torbicki, A. Vahanian, S. Windecker, T. McDonagh, U. Sechtem, L.A. Bonet, P. Avraamides, H.A. Ben Lamin, M. Brignole, A. Coca, P. Cowburn, H. Dargie, P. Elliott, F.A. Flachskampf, G.F. Guida, S. Hardman, B. Iung, B. Merkely, C. Mueller, J.N. Nanas, O.W. Nielsen, S. Orn, J.T. Parissis, P. Ponikowski, and ESC Committee for Practice Guidelines ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur. J. Heart Fail. 14 2012 803 869
18. M. Komajda, S.D. Anker, A. Charlesworth, D. Okonko, M. Metra, A. Di Lenarda, W. Remme, C. Moullet, K. Swedberg, J.G. Cleland, and P.A. Poole-Wilson The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET Eur. Heart J. 27 2006 1440 1446
19. A.L. Kamper, and O.J. Nielsen Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy Scand. J. Clin. Lab. Invest. 50 1990 611 618